Literature DB >> 1343587

Fluoride and phosphatidylserine induced inhibition of cytosolic insulin-degrading activity.

D P Udrisar1, M I Wanderley.   

Abstract

Cytosol (C) (100,000 x g/60 min, supernatant) from liver, brain and testis (Wistar male rats) are shown to contain insulin degrading activity (C-IDA). The regulation of C-IDA in these fractions by ligands that activate G protein and PKC were examined C-IDA from liver, brain and testis was inhibited 76%; 64% and 50% by 50 mM F- respectively. Chromatography of C fraction from liver on Sephadex G-50 in presence of 1 M (NH4)2SO4 and 20% (v/v) glycerol (experimental condition to remove guanine nucleotides from G proteins) decreased in about 3-fold aluminum fluoride effect on C-IDA. Mg++ (from 5mM to 10 mM) enhanced fluoride effects by inhibiting fully C-IDA. Phosphatidylserine in presence of ATP completely inhibited C-IDA; this inhibition was 31.3% mediated by a phosphorylation reaction. It is concluded that cytosol from different tissues contain proteins capable to associate ligands as aluminum fluoride and PS to regulate C-IDA. It is proposed a mechanism of protein-protein interaction to modulate C-IDA.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1343587

Source DB:  PubMed          Journal:  Acta Physiol Pharmacol Ther Latinoam        ISSN: 0327-6309


  3 in total

1.  II - Insulin processing in mitochondria.

Authors:  María Del Carmen Camberos; Adriana A Pérez; Gisel A Passicot; Lucía C Martucci; María I Wanderley; Daniel P Udrisar; Juan C Cresto
Journal:  J Bioenerg Biomembr       Date:  2016-10-29       Impact factor: 2.945

2.  Effect of dexamethasone and testosterone treatment on the regulation of insulin-degrading enzyme and cellular changes in ventral rat prostate after castration.

Authors:  Juliany S B César Vieira; Karina L A Saraiva; Maria C L Barbosa; Regina C C Porto; Juan C Cresto; Christina A Peixoto; Maria I Wanderley; Daniel P Udrisar
Journal:  Int J Exp Pathol       Date:  2011-04-21       Impact factor: 1.925

3.  Glucose inhibits the insulin-induced activation of the insulin-degrading enzyme in HepG2 cells.

Authors:  O Pivovarova; O Gögebakan; A F H Pfeiffer; N Rudovich
Journal:  Diabetologia       Date:  2009-04-25       Impact factor: 10.122

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.